The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
20-Nov-2012 - Medpace has acquired Meditech Strategic Consulting in a bid to expand its European clinical trial services.
14-Nov-2012 - A new personalised medicine-focused partnership for AstraZeneca, expansion in three continents for World Wide clinical and six small CROs team-up to create one super-team. Outsourcing-pharma.com presents a round-up of the...
08-Nov-2012 - Outsourcing-Pharma.com is in Hamburg,Germany this week to meet the CROs, sponsors and academics gathered at PCT Europe to discuss the future of partnerships in clinical trials.
05-Nov-2012 - Eli Lilly is bringing more production in-house after investing $140m in the expansion of its US insulin site.
23-Oct-2012 - Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.
15-Oct-2012 - Piramal Healthcare wants to add sterile injectables to its offering but is unwilling to overpay for facilities owned by 'value focused' private equity groups.
25-Sep-2012 - Clinipace has bought Californian CRO Paragon Biomedical in a bid to expand its therapeutic expertise.
24-Sep-2012 - Carestream Health has offloaded most of its preclinical molecular imaging systems in a deal with Bruker.
20-Sep-2012 - Quintiles has granted Comprehensive Clinical Development first refusal to work on its sponsored clinical trials.
11-Sep-2012 - Isotope technology firm Eckert & Ziegler has acquired bioanalytical CRO Vitalea Science.
06-Sep-2012 - Improving efficiency in biopharma research is a “mixed blessing” for contract research organisations (CROs), according to Wells Fargo.
05-Sep-2012 - Outsourcing-Pharma.com presents a round-up of the latest from the world of contract manufacturing, including extensive jobs cuts for Merck, a monoclonal antibody agreement for Cobra and Algeta and Aesica’s latest...
29-Aug-2012 - Charles River Laboratories has acquired Accugenix in a bid to expand its endotoxin and microbial detection portfolio.
28-Aug-2012 - Health economics and outcomes research teams must have a greater influence over clinical trial design if pharma firms are to achieve reimbursement goals, according to Cutting Edge Information.
07-Aug-2012 - Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and...
01-Aug-2012 - AstraZeneca and Assay Depot have launched a new “virtual research lab” which they say will allow a small group of scientists to run full drug discovery from a laptop....
23-Jul-2012 - SPIC has pressed the Indian PM to issue a standardised excise duty to all contract manufacturers operating in the country so drugsmakers can have a level playing field.
17-Jul-2012 - BioFocus has taken on Titian’s sample management software in a bid to pump more resources into “refreshing” its 900,000 strong high-throughput screening (HTS) compound portfolio.
09-Jul-2012 - No job losses, facility divestitures or strategic changes are planned at DPT Laboratories according to new owner Renaissance Pharma, which bought the CDMO in an out-of-the-blue deal last week.
09-Jul-2012 - iGATE says its new information management platform will provide a 70 per cent decrease in content management costs for the drug development process.
05-Jul-2012 - ‘Merge CDMO and CRO activities to fix the holes in the early phase clinical research industry’, said Quotient Clinical’s CEO Mark Egerton.
03-Jul-2012 - Cutting in-house R&D staff to outsource more activities cuts will drive the industry forward, according to a new report.
28-Jun-2012 - A shortage of staff to serve strategic deals will drive big CROs to scale and consolidate through M&A, an analyst predicts.
27-Jun-2012 - “Collaborate to innovate,” is the message DIA has for clinical researchers at its 2012 Annual Meeting in Philadelphia, US.
25-Jun-2012 - Catalent and Bend Research have joined forces to tackle time and cost restrictions for the complex oral controlled-release development and manufacturing process.